SEARCH

User ID: 999999
Version: 4.37.48

www.memory.co.uk
You are in browse mode. You must login to use MEMORY

   Log in to start


« Previous
Next »
From course:

CPO Biologiques

» Start this Course
(Practice similar questions for free)
Question:

Atezolizumab (Tecentriq)

Author: Natalia Abesada


Answer:

Anti PD-L1. Ind: monotherapie dans le carcinome urotheliale, cancer bronchique. En association: Cancer du sein triple negatif, dont les tumeurs expriment PD-L1.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Natalia Abesada
Natalia Abesada